Scottsdale, Arizona, Jan. 18, 2022 -- McapMediaWire -- Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following: The Company is proud to announce the entry into a Letter of Intent with SPUR Biotech, LLC (“SPUR”), an Ohio-based developer of plant-based vaccines. SPUR is a biotechnology company developing plant-based vaccines using Controlled Environment Agriculture (CEA) to sustainably grow leafy greens and biopharmaceuticals. The vaccine under...
SIBANNAC, INC. AND SPUR BIOTECH, LLC ENTER LETTER OF INTENT TO MARKET PLANT BASED VACCINE
read more